Are you Dr. Hatanpaa?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 42 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Dallas, TX 75390Phone+1 214-648-1620Fax+1 214-648-4080
Summary
- Dr. Kimmo Hatanpaa, MD is a board certified pathologist in Dallas, Texas. He is currently licensed to practice medicine in Texas and Utah. He is affiliated with University of Texas Southwestern Medical Center, Children's Medical Center Dallas, and Dallas Medical Center.
Education & Training
Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2000 - 2002
Yale-New Haven Medical CenterResidency, Pathology-Anatomic and Clinical, 1998 - 2000
Certifications & Licensure
TX State Medical License 2002 - 2025
UT State Medical License 2000 - 2004- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Clinical Trials
- An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection Start of enrollment: 2009 Aug 01
Publications & Presentations
PubMed
- 314 citationsEpidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance.Kimmo J. Hatanpaa, Sandeep Burma, Dawen Zhao, Amyn A. Habib
Neoplasia. 2010-09-01 - 158 citationsThe Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor GrowthCalin O. Marian, Steve K. Cho, Brian M. Mcellin, Elizabeth A. Maher, Kimmo J. Hatanpaa
Clinical Cancer Research. 2010-01-01 - 116 citationsTMEM106B protects C9ORF72 expansion carriers against frontotemporal dementiaMarka van Blitterswijk, Bianca Mullen, Alexandra M. Nicholson, Kevin F. Bieniek, Michael G. Heckman
Acta Neuropathologica. 2014-01-03
Press Mentions
Double-Drug Strategy Blocks Escape Route for Most Lung CancersApril 5th, 2018- Study: New Approach to Destroying Deadly Brain TumorsJune 13th, 2017
Potential New Target for Treating GlioblastomaFebruary 25th, 2017
